COSA 2014* , ,
Presentations this author is a contributor to:
Cetuximab use in metastatic colorectal cancer at five large Queensland public hospitals: comparison to key clinical trials (#277)
3:00 PM
Daniel McKavanagh
Poster discussion 1
Is bevacizumab in metastatic colorectal cancer effectiveness comparable to key Pharmaceutical Benefits Scheme submission clinical trials? Usage results from five large Queensland public hospitals (#394)
3:00 PM
Daniel McKavanagh
Poster discussion 2